GAYLA CULPEPPER: Open Payments
NPI 1861467631 · DEMOPOLIS, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$274 in 14 payments from 6 companies in 2025. Trend: 2023 $282 · 2024 $472 · 2025 $274
Food & beverage: $274
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $81 |
| Dexcom, Inc. | 2 | $49 |
| Novo Nordisk Inc | 3 | $49 |
| Novartis Pharmaceuticals Corporation | 2 | $39 |
| Janssen Pharmaceuticals, Inc | 2 | $39 |
| Boston Scientific Corporation | 1 | $17 |
Products named: VRAYLAR, Dexcom G6 Transmitter, LEQVIO, SPRAVATO, Wegovy, QULIPTA, General - Pain Management, Ozempic.
Industry payments across AL — which companies pay providers there.
